135 related articles for article (PubMed ID: 6435528)
21. A triple-binding-domain model explains the specificity of the interaction of a sphingolipid activator protein (SAP-1) with sulphatide, GM1-ganglioside and globotriaosylceramide.
Wynn CH
Biochem J; 1986 Dec; 240(3):921-4. PubMed ID: 3827882
[TBL] [Abstract][Full Text] [Related]
22. Uptake and metabolism of radiolabelled GM1-ganglioside in skin fibroblasts from controls and patients with GM1-gangliosidosis.
Midorikawa M; Inui K; Okada S; Yabuuchi H; Ogura K; Handa S
J Inherit Metab Dis; 1991; 14(5):721-9. PubMed ID: 1779618
[TBL] [Abstract][Full Text] [Related]
23. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.
Hechtman P; Gordon BA; Ng Ying Kin NM
Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612
[TBL] [Abstract][Full Text] [Related]
24. Patterns of complex carbohydrate storage in four lysosomal storage diseases: fucosidosis, GM1-gangliosidosis, GM2-gangliosidosis (Sandhoff variant) and mannosidosis.
Dawson G; Chen Tsay G
Biochem Exp Biol; 1977; 13(1):15-25. PubMed ID: 418790
[No Abstract] [Full Text] [Related]
25. Clinical, pathological, and biochemical studies on an infantile case of sulfatide/GM1 activator protein deficiency.
Wenger DA; DeGala G; Williams C; Taylor HA; Stevenson RE; Pruitt JR; Miller J; Garen PD; Balentine JD
Am J Med Genet; 1989 Jun; 33(2):255-65. PubMed ID: 2764035
[TBL] [Abstract][Full Text] [Related]
26. Binding of GM1 ganglioside to a synthetic peptide derived from the lysosomal sphingolipid activator protein saposin B.
Champagne MJ; Lamontagne S; Potier M
FEBS Lett; 1994 Aug; 349(3):439-41. PubMed ID: 8050611
[TBL] [Abstract][Full Text] [Related]
27. Binding of GM1-ganglioside to a synthetic peptide derived from the lysosomal sphingolipid-activator-protein saposin B.
Champagne MJ; Lamontagne S; Potier M
FEBS Lett; 1994 Jun; 347(2-3):265-7. PubMed ID: 8034015
[TBL] [Abstract][Full Text] [Related]
28. A case of GM1-gangliosidosis type I: glycosphingolipid profiles of urine and transformed lymphocytes and beta-D-galactosidase activities in peripheral lymphocytes, cultured skin fibroblasts and transformed lymphocytes.
Asano K; Shindo N; Nakasuji M; Inamori K; Ohta M; Matsushita T; Yamaguchi M; Oshima M
Jpn J Exp Med; 1990 Apr; 60(2):73-9. PubMed ID: 2117086
[TBL] [Abstract][Full Text] [Related]
29. [The metabolism of radiolabelled GM1-ganglioside in cultured skin fibroblasts from controls and patients with GM1-gangliosidosis].
Inui K
Nihon Rinsho; 1995 Dec; 53(12):3102-4. PubMed ID: 8577066
[TBL] [Abstract][Full Text] [Related]
30. Application of a GM1 ganglioside beta-galactosidase microassay method to diagnosis of GM1 gangliosidosis.
Mutoh T; Kiuchi K; Sobue I; Naoi M
Clin Chim Acta; 1984 Jul; 140(3):223-30. PubMed ID: 6432371
[TBL] [Abstract][Full Text] [Related]
31. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
Inui K; Wenger DA
J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115
[TBL] [Abstract][Full Text] [Related]
32. Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases.
Morimoto S; Yamamoto Y; O'Brien JS; Kishimoto Y
Proc Natl Acad Sci U S A; 1990 May; 87(9):3493-7. PubMed ID: 2110365
[TBL] [Abstract][Full Text] [Related]
33. A case of type 2 Gm1-gangliosidosis with long survival.
Kikuchi K; Minami R; Kudoh T; Nakao T; Tsugawa S
Brain Dev; 1982; 4(2):153-6. PubMed ID: 6807121
[TBL] [Abstract][Full Text] [Related]
34. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins).
Hiraiwa M; O'Brien JS; Kishimoto Y; Galdzicka M; Fluharty AL; Ginns EI; Martin BM
Arch Biochem Biophys; 1993 Jul; 304(1):110-6. PubMed ID: 8323276
[TBL] [Abstract][Full Text] [Related]
35. Combined sialidase (neuraminidase) and beta-galactosidase deficiency. Clinical, morphological and enzymological observations in a patient.
Loonen MC; Reuser AJ; Visser P; Arts WF
Clin Genet; 1984 Aug; 26(2):139-49. PubMed ID: 6432381
[TBL] [Abstract][Full Text] [Related]
36. The abnormalities of beta-galactosidase in GM1-gangliosidoses.
Kudoh T
Tohoku J Exp Med; 1978 May; 125(1):93-101. PubMed ID: 27879
[TBL] [Abstract][Full Text] [Related]
37. [The use of loading tests with labeled GM1-ganglioside for differential diagnosis of GM1-gangliosidosis].
Akhunov VS; Krasnopol'skaia KD; Mirenburg TV
Vopr Med Khim; 1989; 35(5):119-22. PubMed ID: 2515652
[TBL] [Abstract][Full Text] [Related]
38. The biochemical basis of gangliosidoses.
Sandhoff K; Conzelmann E
Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704
[No Abstract] [Full Text] [Related]
39. Regional localization of the gene coding for sphingolipid activator protein SAP-1 on human chromosome 10.
Kao FT; Law ML; Hartz J; Jones C; Zhang XL; Dewji N; O'Brien JS; Wenger DA
Somat Cell Mol Genet; 1987 Nov; 13(6):685-8. PubMed ID: 3478817
[TBL] [Abstract][Full Text] [Related]
40. GM1-ganglioside beta-galactosidase in leukocytes and cultured fibroblasts.
Raghavan SA; Gajewski A; Kolodny EH
Clin Chim Acta; 1977 Nov; 81(1):47-56. PubMed ID: 411612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
